U.S. Markets open in 6 hrs 35 mins

Pfizer's Stock Ready for a 10% Rebound

Pfizer Inc. ( PFE) shares have dramatically underperformed during the past three years, rising 9.4% compared to the S&P 500's rise of nearly 31%. Options traders are also betting the stock will gain in the next few months. Pfizer has not only underperformed the broader stock market, but its valuation is among the cheapest of some of the other big pharmaceuticals.